
Loading, please wait...

Loading, please wait...

Acute ischaemic stroke requires rapid neuroimaging interpretation to guide urgent revascularization therapy and prevent irreversible disability. Non-contrast computed tomography remains the first-line imaging modality in emergency departments worldwide due to its widespread availability and speed. However, expert interpretation can face delays, potentially compromising critical treatment windows. Automated machine learning tools offer real-time decision support, but traditional algorithms rely heavily on labor-intensive pixel-level image annotation. To address this bottleneck, researchers recently evaluated an innovative artificial intelligence framework capable of performing automated ischaemic stroke lesion detection using routinely collected CT brain scans without manual lesion annotation.
Non-contrast brain CT is the essential diagnostic scan for evaluating acute neurological deficits. Clinicians rely on emergency CT imaging to rule out intracranial hemorrhage prior to initiating intravenous thrombolysis or preparing for endovascular thrombectomy. However, subtle hypodensity associated with early ischemic injury is often challenging to detect during hyperacute presentations. Non-specialist clinicians and junior emergency physicians frequently encounter difficulties identifying early parenchymal subtle density changes. Moreover, persistent radiologist shortages in non-urban centers can delay definitive diagnostic reports when time is of the essence.
Artificial intelligence applications provide a promising approach to support rapid clinical triage. Nevertheless, conventional deep learning models require extensive slice-by-slice manual annotations by expert neuroradiologists. This tedious annotation process severely limits the scale and demographic diversity of development datasets. Consequently, many algorithms demonstrate reduced accuracy when tested on heterogeneous real-world patient populations. Leveraging unannotated clinical CT scans provides a scalable solution to train robust deep learning models across large clinical datasets.
To evaluate whether artificial intelligence can learn without spatial bounding, investigators designed a convolutional neural network architecture using unannotated head CT scans. The deep learning model was trained using routinely acquired scans from a large, multicenter international stroke trial. Instead of slice-by-slice manual tracing, expert neuroradiologists provided overall patient-level labels for acute and chronic radiological features. The model utilized weakly supervised learning to identify ischemic injury patterns directly from study-level classifications.
The training dataset comprised 5,772 CT scans from 2,347 patients with a median age of 82 years. These clinical scans reflected authentic real-world scanner variability, motion artifacts, and inconsistent image resolution. Expert clinical evaluation confirmed visible acute ischaemic lesions in 54% of the scans. By training on routinely collected clinical data, researchers established a framework capable of utilizing vast institutional imaging repositories without requiring manual annotation.
The deep learning model achieved an overall accuracy of 72% in detecting acute ischaemic lesions across the complete testing dataset. This diagnostic performance confirms that convolutional networks can extract key features of acute cerebral ischemia without spatial guidance during training. The algorithm successfully identified subtle parenchymal hypoattenuation caused by early cytotoxic edema and correctly classified the affected brain hemisphere.
This level of accuracy is notable considering the advanced age of the study population. The median patient age of 82 years introduced common age-related brain changes, such as white matter changes and cortical atrophy, which routinely obscure early infarct identification. Although a 72% accuracy rate indicates that standalone automated interpretation requires further refinement, the algorithm demonstrates significant utility as an automated triage tool to support emergency clinical workflows.
Subgroup analysis demonstrated that lesion characteristics and imaging timing heavily influenced model performance. Detection accuracy increased significantly for larger territorial infarctions, reaching 80%. The model performed remarkably well when evaluating multifocal ischaemic changes, achieving 87% accuracy for two distinct lesions and 100% accuracy when three or more acute lesions were present. Multiple acute lesions provided stronger spatial signals across consecutive CT slices.
Imaging timing relative to symptom onset also impacted diagnostic success. Follow-up scans acquired 24 to 48 hours post-stroke achieved 76% accuracy, compared with 67% accuracy for baseline hyperacute scans. As ischemic edema progresses, tissue density drops, creating clearer contrast against healthy surrounding parenchyma. These findings underscore the temporal evolution of ischemic changes on non-contrast imaging and demonstrate how progressive radiological visibility enhances deep learning performance.
The evaluation revealed significant challenges presented by background brain abnormalities and pre-existing chronic conditions. Pre-existing non-stroke abnormalities and old chronic stroke infarcts were the primary sources of diagnostic errors. Non-stroke structural abnormalities resulted in an error rate of 32%, while old stroke lesions produced a 31% error rate. Chronic encephalomalacia creates persistent low-density areas that closely resemble acute ischemic hypodensity.
These diagnostic errors emphasize the difficulty of distinguishing hyperacute cytotoxic edema from chronic structural changes on single non-contrast CT scans without baseline comparisons. Experienced radiologists rely on anatomical distribution, sharp encephalomalacic margins, and clinical history to differentiate old strokes from hyperacute ischemia. Future deep learning iterations must incorporate longitudinal imaging or patient clinical data to reduce false positive classifications caused by chronic parenchymal changes.
Developing deep learning models without spatial annotation offers substantial benefits for global stroke care. By removing the burden of manual annotation, researchers can utilize massive, uncurated hospital databases containing thousands of routine brain scans. This scalable approach enables artificial intelligence models to train on representative patient populations, incorporating diverse scanner hardware and patient demographics. Scalability is essential for building software that performs reliably in diverse emergency departments.
In clinical practice, automated lesion detection systems are designed to assist emergency clinicians rather than replace certified radiologists. These models can rapidly flag high-probability abnormal scans, prioritizing them in the radiologist worklist to shorten time-to-treatment. Accelerated image triage facilitates prompt thrombolysis or endovascular thrombectomy decisions, ultimately improving functional outcomes for acute stroke patients.
Traditional stroke algorithms require labor-intensive manual slice-by-slice image annotations created by expert radiologists. In contrast, this deep learning model uses unannotated CT brain scans with study-level expert labels. This allows the network to learn directly from massive, routinely collected clinical datasets without requiring manual drawing on individual images.
The deep learning model achieved 72% overall accuracy across 5,772 CT scans from 2,347 patients. Accuracy increased to 80% for larger infarctions, up to 100% for three or more lesions, and 76% for follow-up scans acquired 24 to 48 hours after stroke onset.
Pre-existing chronic brain pathologies caused notable diagnostic errors. Specifically, non-stroke structural lesions and old stroke infarcts resulted in error rates of 32% and 31%, respectively. Chronic encephalomalacia creates persistent low-density areas that the algorithm occasionally misclassified as hyperacute ischaemic lesions on non-contrast scans.
Disclaimer: This content is for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new deep learning algorithm trained on unannotated head CT scans demonstrated 72% accuracy in detecting acute ischaemic stroke lesions. Accuracy reached 80% for large lesions and 100% for multifocal ischemia, highlighting a scalable approach for automated emergency neuroimaging triage.
Today

Researchers at SGPGIMS Lucknow have isolated and cultured human heart valve interstitial cells from donor tissues. This milestone advances understanding of rheumatic heart disease pathways like TGF-beta/SMAD3 and ERK1/2, laying the foundation for tissue-engineered heart valves and drug testing.
Today

A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
6 days back

A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
4 days back

Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
3 days back

Deepinder Goyal's healthtech startup Temple is raising capital at a $500 million valuation and pricing its temporal wearable at Rs 80,000. Worn on the side of the forehead, the device tracks microvascular blood flow and real-time Entropy to monitor physiological stress, metabolic expenditure, and recovery.
Today